Cargando…
A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies
Meropenem is a carbapenem antibiotic that exhibits time-dependent bactericidal activity, traditionally dosed intravenously at 1 g every 8 h. In order to maximize its pharmacodynamic activity and reduce costs, an alternative regimen employed by many institutions is 500 mg every 6 h. The objective of...
Autores principales: | Wilby, Kyle John, Nasr, Ziad Ghantous, Elazzazy, Shereen, Lau, Tim T. Y., Hamad, Anas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318341/ https://www.ncbi.nlm.nih.gov/pubmed/28101836 http://dx.doi.org/10.1007/s40268-017-0173-0 |
Ejemplares similares
-
Bridging theory and practice: Mixed methods approach to instruction of law and ethics within the pharmaceutical sciences
por: Wilby, Kyle John, et al.
Publicado: (2016) -
Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study
por: Nasser, Sahar M, et al.
Publicado: (2019) -
Pharmacokinetics of meropenem in critically ill patients in Saudi Arabia
por: Alsultan, Abdullah, et al.
Publicado: (2021) -
Perceptions and expectations of health care providers towards
clinical pharmacy services at a tertiary cancer centre in Qatar
por: Omar, Nabil E, et al.
Publicado: (2019) -
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation
por: Al-Ziftawi, Nour Hisham, et al.
Publicado: (2022)